News | Laboratorio Reig Jofre

2 December 2025

REIG JOFRE acquires Leanbio and strengthens its vertical integration in biotechnology

5 November 2025

REIG JOFRE publishes its 2025 nine-months financial results

9 October 2025

The European Commission visits REIG JOFRE’s Barcelona plant as part of its vaccine manufacturing strategy

25 July 2025

REIG JOFRE publishes its 2025 first half financial results

27 May 2025

Bioglan Opens Cutting-Edge Facility as Swedish Innovation Powers a New Era in Parkinson’s Treatment

9 May 2025

REIG JOFRE publishes its 2025 first quarter financial results

8 May 2025

REIG JOFRE to receive €13 million from CDTI to drive pharmaceutical innovation within the framework of the European IPCEI Med4Cure project

26 March 2025

REIG JOFRE and LEO PHARMA join forces to improve access to an innovative psoriasis treatment in Primary Care

28 February 2025

REIG JOFRE publishes its 2024 financial results

26 February 2025

REIG JOFRE strengthens its dermatology portfolio with the launch of Vincobiosis® Acneic for acne-prone skin

15 January 2025

REIG JOFRE appoints Teresa Pérez de Prada as Director of its antibiotic development and production plant in Toledo

31 October 2024

REIG JOFRE submits press release on 2024 third quarter results

18 September 2024

REIG JOFRE participates in a Consortium to validate and scale-up the human skin production generated by a 3D bioprinter

10 September 2024

REIG JOFRE opens a subsidiary in Czech Republic

30 July 2024

REIG JOFRE submits press release on the results of the first half of 2024

18 June 2024

REIG JOFRE joins the IBEX SMALL CAP INDEX

29 May 2024

REIG JOFRE participates as an Associated Partner in Med4Cure, the first major European project for the industrialization of new therapies

10 May 2024

REIG JOFRE submits the conditions and report of the Scrip Dividend

9 May 2024

REIG JOFRE submits press release on the results of the first quarter of 2024

8 April 2024

REIG JOFRE commits to vertical integration in the production of biotechnological medicines with an investment of eur 5.8m in Leanbio